Waters Corporation is a global leader in specialized measurement, delivering analytical solutions across Asia, the Americas, and Europe. The company operates through two main divisions: Waters and TA. Under its Waters segment, it engineers, manufactures, sells, and provides support for high and ultra-performance liquid chromatography and mass spectrometry (MS) systems. This includes essential consumables like chromatography columns and comprehensive post-warranty service plans. The TA segment focuses on designing, producing, selling, and servicing instruments for thermal analysis, rheometry, and calorimetry. Additionally, Waters develops and supplies sophisticated software that integrates with both its own instruments and those from other manufacturers. The company's advanced MS technology plays a crucial role in various applications, such as drug discovery and development (including clinical trial assessments), analyzing proteins involved in disease processes, ensuring nutritional safety, and conducting environmental testing. Its thermal analysis, rheometry, and calorimetry instruments are vital for assessing the suitability and stability of a wide range of materials, including fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids. These instruments support diverse sectors like industrial manufacturing, consumer goods, healthcare products, and life science research. Waters' extensive client base spans the life sciences, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental sectors, where its products are instrumental in research and development, quality assurance, and general laboratory operations. Established in 1958, Waters Corporation is headquartered in Milford, Massachusetts.
CEO: Udit Batra. Company website
Waters Corporation (WAT) trades at $421.63, down 1.88% on the day, as of Sep 20, 2026 13:46 UTC.
Waters Corporation has a market capitalisation of $31.53B, calculated from the live WAT share price and shares outstanding.
WAT trades at a trailing P/E of 105.14, from earnings per share of $4.01 over the last twelve months.
Waters Corporation generated revenue of $4.64B over the trailing twelve months, which puts the stock at 6.79 times sales.
WAT has traded between $282.77 and $431.78 over the past 52 weeks, and the last price is 2.4% below that high.
Yes. Waters Corporation keeps 3.58% of revenue as net income over the trailing twelve months.
Wall Street analysts rate WAT Buy, with an average price target of $438.36, 4.0% above the current price.
Waters Corporation is classified under the Healthcare sector and the Medical - Diagnostics & Research industry, and is domiciled in US.
Udit Batra is the chief executive of Waters Corporation, which employs 7,900 people.
QFI Terminal shows WAT with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open WAT in Terminal See plans